Feb 14, 2013, 02.09 PM IST
Shares in Dr Reddy's Laboratories fall 2.1 percent on worries the drug maker will post lower-than-expected October-December earnings, due later in the day
Margins are also expected to see significant erosion, several dealers add.
Dr Reddy's could miss consensus earnings per share (EPS) estimates by 6 percent in the October-December quarter, according to Thomson Reuters StarMine SmartEstimate data, which measures the forecasts from top-ranked analysts against wider forecasts. * StarMine SmartEstimate suggests EPS for the quarter ending December at Rs 26.03 compared with mean estimate of Rs 27.89.
Dr Reddys Labs stock price
On December 10, 2013, Dr Reddys Laboratories closed at Rs 2450.80, up Rs 1.30, or 0.05 percent. The 52-week high of the share was Rs 2545.00 and the 52-week low was Rs 1720.50.
The company's trailing 12-month (TTM) EPS was at Rs 91.89 per share as per the quarter ended September 2013. The stock's price-to-earnings (P/E) ratio was 26.67. The latest book value of the company is Rs 457.59 per share. At current value, the price-to-book value of the company is 5.36.
Action in Dr Reddys Laboratories
Video of the day
Dec 10 2013, 11:21
- in FII View
Dec 4 2013, 11:08
- in FII View
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.